Suppr超能文献

肠道对尿毒症溶质的贡献。

Colonic contribution to uremic solutes.

机构信息

Vincent Coates Foundation Mass Spectrometry Laboratory, Stanford University, Stanford, California, USA.

出版信息

J Am Soc Nephrol. 2011 Sep;22(9):1769-76. doi: 10.1681/ASN.2010121220. Epub 2011 Jul 22.

Abstract

Microbes in the colon produce compounds, normally excreted by the kidneys, which are potential uremic toxins. Although p-cresol sulfate and indoxyl sulfate are well studied examples, few other compounds are known. Here, we compared plasma from hemodialysis patients with and without colons to identify and further characterize colon-derived uremic solutes. HPLC confirmed the colonic origin of p-cresol sulfate and indoxyl sulfate, but levels of hippurate, methylamine, and dimethylamine were not significantly lower in patients without colons. High-resolution mass spectrometry detected more than 1000 features in predialysis plasma samples. Hierarchical clustering based on these features clearly separated dialysis patients with and without colons. Compared with patients with colons, we identified more than 30 individual features in patients without colons that were either absent or present in lower concentration. Almost all of these features were more prominent in plasma from dialysis patients than normal subjects, suggesting that they represented uremic solutes. We used a panel of indole and phenyl standards to identify five colon-derived uremic solutes: α-phenylacetyl-l-glutamine, 5-hydroxyindole, indoxyl glucuronide, p-cresol sulfate, and indoxyl sulfate. However, compounds with accurate mass values matching most of the colon-derived solutes could not be found in standard metabolomic databases. These results suggest that colonic microbes may produce an important portion of uremic solutes, most of which remain unidentified.

摘要

结肠中的微生物会产生化合物,这些化合物通常会被肾脏排出,它们是潜在的尿毒症毒素。虽然对邻苯二酚硫酸盐和吲哚硫酸酯已有深入研究,但人们对其他化合物知之甚少。在这里,我们比较了有结肠和无结肠的血液透析患者的血浆,以鉴定和进一步描述源自结肠的尿毒症溶质。HPLC 证实了邻苯二酚硫酸盐和吲哚硫酸酯的结肠来源,但无结肠患者的马尿酸、甲胺和二甲胺水平并没有显著降低。高分辨率质谱检测到预透析血浆样本中存在 1000 多种特征。基于这些特征的层次聚类清楚地将有结肠和无结肠的透析患者区分开来。与有结肠的患者相比,我们在无结肠的患者中发现了 30 多种特征,这些特征要么不存在,要么存在浓度较低。几乎所有这些特征在无结肠的透析患者中比在正常受试者中更为突出,这表明它们代表尿毒症溶质。我们使用一组吲哚和苯标准品来鉴定五种源自结肠的尿毒症溶质:α-苯乙酰基-l-谷氨酰胺、5-羟基吲哚、吲哚基葡萄糖醛酸、邻苯二酚硫酸盐和吲哚硫酸酯。然而,在标准代谢组学数据库中无法找到与大多数源自结肠的溶质具有准确质量值的化合物。这些结果表明,结肠微生物可能会产生大量尿毒症溶质,其中大多数仍未被识别。

相似文献

1
Colonic contribution to uremic solutes.肠道对尿毒症溶质的贡献。
J Am Soc Nephrol. 2011 Sep;22(9):1769-76. doi: 10.1681/ASN.2010121220. Epub 2011 Jul 22.
4
Uremic solutes from colon microbes.肠道微生物来源的尿毒症溶质。
Kidney Int. 2012 May;81(10):949-954. doi: 10.1038/ki.2011.504. Epub 2012 Feb 8.
5
An Enlarged Profile of Uremic Solutes.尿毒症溶质的扩大概况。
PLoS One. 2015 Aug 28;10(8):e0135657. doi: 10.1371/journal.pone.0135657. eCollection 2015.
8
Uremic Solutes Produced by Colon Microbes.结肠微生物产生的尿毒症溶质。
Blood Purif. 2015;40(4):306-11. doi: 10.1159/000441578. Epub 2015 Nov 17.

引用本文的文献

本文引用的文献

2
Indoxyl sulfate is a nephro-vascular toxin.硫酸吲哚酚是一种肾血管毒素。
J Ren Nutr. 2010 Sep;20(5 Suppl):S2-6. doi: 10.1053/j.jrn.2010.05.002.
3
Metabolite profiling identifies markers of uremia.代谢组学分析鉴定出尿毒症的标志物。
J Am Soc Nephrol. 2010 Jun;21(6):1041-1051. doi: 10.1681/ASN.2009111132. Epub 2010 Apr 8.
4
The gut: the forgotten organ in uremia?肠道:尿毒症中被遗忘的器官?
Blood Purif. 2010;29(2):130-6. doi: 10.1159/000245639. Epub 2010 Jan 8.
6
Methylamine clearance by haemodialysis is low.血液透析清除甲胺的能力较低。
Nephrol Dial Transplant. 2010 May;25(5):1608-13. doi: 10.1093/ndt/gfp629. Epub 2009 Dec 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验